2014-15 Funded Research Research & Impact What We Fund 2014-15 Funded ResearchResearch We Funded in 2014-15Three Post-Doctoral FellowshipsAwarded to support post-doctoral scientists whose research training holds promise into new insights of geriatric psychology, pathophysiology, etiology and treatment of Parkinson’s disease. This is a fellowship of $35,000 per year for one year.Peter Ash, PhDTrustees of Boston University Environmental toxicant-agonists of the Aryl hydrocarbon Receptor induce expression of alpha synucleinNebojsa Kezunovic, PhDIcahn School of Medicine at Mount Sinai Impact of PD-related mutation of LRRK2 on striatal synapse development and functionKhoa Nguyen, PhDStanford University Defining the role of microglia-specific LRRK2 in Parkinson’s diseaseSeven Research GrantsAwarded for junior investigators to pursue research in Parkinson’s disease. The applicant must be affiliated with and perform the research project at an academic institution. This is a grant of $50,000 per year for one year, renewable.Theresa Ellis, PhDBoston University Mobile Health Technology (MHT) to Promote Physical Activity in Persons with PDSamual A. Frank, MDBoston University Mortality in PD: The PEACE ConsortiumCristina Guardia Laguarta, PhDColumbia University A new role for alpha synuclein in Parkinson’s disease: Alteration of ER-mitochondria communicationDaniel Lawrence, PhDUniversity of Michigan Identification and evaluation of a novel therapeutic target for Parkinson’s diseaseLaura Volpicelli-Daley, PhDUniversity of Alabama at Birmingham LRRK2 in Pathological Synuclein TransmissionTalene Yacoubian, MD, PhDUniversity of Alabama at Birmingham Effects of 14-3-3s on Alpha Synuclein Release and ToxicityJinbin Xu, PhDWashington University Peripheral Benzodiazepine Receptor as a Biomarker for Imaging Nigrostriatal NeuronsSummer Student FellowshipsBrice KesslerUniversity of North Carolina School of Medicine Use of preoperative 7T resting BOLD fMRI as an adjunct tool to guide lead placement in deep brain stimulation surgery for Parkinson’s diseaseQuynh VoPenn State Milton S. Hershey Medical Center Characterization and development of a reliable and reproducible rat model of REM behavioral disorder associated with Parkinson’s diseaseShare this page:
